Kura Oncology
Jasmine Hellings possesses significant expertise in commercial insights and analytics, currently serving as Senior Director at Kura Oncology, Inc. Previously, Jasmine held the role of Senior Manager in Market Planning at Array BioPharma Inc. Additionally, Jasmine is an MBA candidate from the Haas School of Business, class of 2012, showcasing a strong academic background in business and market strategy.
This person is not in any teams
This person is not in any offices
Kura Oncology
20 followers
Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Our small-molecule drug candidates target signaling pathways and other drivers of cancer where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment.